Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Lenalidomide Krka d.d., lenalidomide, Multiple Myeloma;Lymphoma, Follicular;Myelodysplastic Syndromes, Date of authorisation: 11/02/2021, Revision: 2, Status: Withdrawn
TO: